{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:18:39Z","timestamp":1792783119118,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Key Project of Postgraduate Scientific Research Innovation Program of Hunan Provincial Department of Education","award":["CX20251151"],"award-info":[{"award-number":["CX20251151"]}]},{"name":"The key research project of Hunan Provincial Administration of Traditional Chinese Medicine","award":["C2023013"],"award-info":[{"award-number":["C2023013"]}],"id":[{"id":"https:\/\/ror.org\/03x55t826","id-type":"ROR","asserted-by":"crossref"}]},{"name":"The key project of the University-Hospital Joint Fund of Hunan University of Chinese Medicine","award":["2025XYLH002"],"award-info":[{"award-number":["2025XYLH002"]}]},{"name":"The Natural Science Foundation of Hunan Province of China","award":["2025JJ90006"],"award-info":[{"award-number":["2025JJ90006"]}]},{"name":"Hunan Provincial Clinical Medical Research Center for Ophthalmic Diseases","award":["2023SK4038"],"award-info":[{"award-number":["2023SK4038"]}]},{"name":"Project for Improving Clinical Evidence-based Capacity of Advantageous Diseases Treated with Traditional Chinese Medicine","award":["JBGS-A1-02"],"award-info":[{"award-number":["JBGS-A1-02"]}]},{"name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","award":["82374525"],"award-info":[{"award-number":["82374525"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"General Program of State Key Laboratories","award":["QZSYS20260902"],"award-info":[{"award-number":["QZSYS20260902"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12925-1","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:02:14Z","timestamp":1792155734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stage-dependent signaling networks and therapeutic strategies in diabetic retinopathy: from neurovascular dysfunction to angiogenesis and fibrosis"],"prefix":"10.1007","volume":"53","author":[{"given":"Wen","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peijuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"12925_CR1","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","volume":"128","author":"ZL Teo","year":"2021","unstructured":"Teo ZL, Tham YC, Yu M et al (2021) Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology 128:1580\u20131591 2021\/05\/04. https:\/\/doi.org\/10.1016\/j.ophtha.2021.04.027","journal-title":"Ophthalmology"},{"issue":"Suppl 1","key":"12925_CR2","doi-asserted-by":"publisher","first-page":"S261","DOI":"10.2337\/dc26-S012","volume":"49","author":"American Diabetes Association Professional Practice Committee for Diabetes*","year":"2026","unstructured":"American Diabetes Association Professional Practice Committee for Diabetes* (2026) 12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes-2026. Diabetes Care 49(Suppl 1):S261\u2013S276. https:\/\/doi.org\/10.2337\/dc26-S012","journal-title":"Diabetes Care"},{"key":"12925_CR3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1056\/NEJMra1005073","volume":"366","author":"DA Antonetti","year":"2012","unstructured":"Antonetti DA, Klein R, Gardner TW (2012) Diabetic retinopathy. N Engl J Med 366:1227\u20131239 2012\/03\/30. https:\/\/doi.org\/10.1056\/NEJMra1005073","journal-title":"N Engl J Med"},{"key":"12925_CR4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaophthalmol.2018.3255","volume":"136","author":"JG Gross","year":"2018","unstructured":"Gross JG, Glassman AR, Liu D et al (2018) Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial. JAMA Ophthalmol 136:1138\u20131148. 2018\/07\/26","journal-title":"JAMA Ophthalmol"},{"key":"12925_CR5","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jama.2022.25029","volume":"329","author":"RK Maturi","year":"2023","unstructured":"Maturi RK, Glassman AR, Josic K et al (2023) Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy. JAMA 329:376\u2013385. 2023\/02\/08","journal-title":"JAMA"},{"key":"12925_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9121244","author":"T Yumnamcha","year":"2020","unstructured":"Yumnamcha T, Guerra M, Singh LP et al (2020) Metabolic Dysregulation and Neurovascular Dysfunction in Diabetic Retinopathy. Antioxid (Basel Switzerland). 9 2020\/12\/12 https:\/\/doi.org\/10.3390\/antiox9121244","journal-title":"Antioxid (Basel Switzerland)"},{"key":"12925_CR7","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/ars.2009.2932","volume":"13","author":"SA Madsen-Bouterse","year":"2010","unstructured":"Madsen-Bouterse SA, Mohammad G, Kanwar M et al (2010) Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression. Antioxid Redox Signal 13:797\u2013805. 2010\/01\/22","journal-title":"Antioxid Redox Signal"},{"key":"12925_CR8","doi-asserted-by":"crossref","first-page":"8791","DOI":"10.1167\/iovs.11-8203","volume":"52","author":"JM Santos","year":"2011","unstructured":"Santos JM, Kowluru RA (2011) Role of mitochondria biogenesis in the metabolic memory associated with the continued progression of diabetic retinopathy and its regulation by lipoic acid. Investig Ophthalmol Vis Sci 52:8791\u20138798. 2011\/10\/18","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR9","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1167\/iovs.13-11598","volume":"54","author":"Q Zhong","year":"2013","unstructured":"Zhong Q, Mishra M, Kowluru RA (2013) Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy. Investig Ophthalmol Vis Sci 54:3941\u20133948. 2013\/05\/02","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR10","doi-asserted-by":"crossref","first-page":"7256","DOI":"10.1167\/iovs.14-15193","volume":"55","author":"M Mishra","year":"2014","unstructured":"Mishra M, Zhong Q, Kowluru RA (2014) Epigenetic modifications of Keap1 regulate its interaction with the protective factor Nrf2 in the development of diabetic retinopathy. Investig Ophthalmol Vis Sci 55:7256\u20137265. 2014\/10\/11","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR11","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1167\/iovs.17-22920","volume":"59","author":"D Deliyanti","year":"2018","unstructured":"Deliyanti D, Alrashdi SF, Tan SM et al (2018) Nrf2 Activation Is a Potential Therapeutic Approach to Attenuate Diabetic Retinopathy. Investig Ophthalmol Vis Sci 59:815\u2013825. 2018\/02\/08","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR12","doi-asserted-by":"publisher","first-page":"9334","DOI":"10.1038\/s41467-024-53601-x","volume":"15","author":"Y Lei","year":"2024","unstructured":"Lei Y, Liu Q, Chen B et al (2024) Protein O-GlcNAcylation coupled to Hippo signaling drives vascular dysfunction in diabetic retinopathy. Nat Commun 15:9334. 2024\/10\/30","journal-title":"Nat Commun"},{"key":"12925_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s12035-023-03534-1","volume":"61","author":"RA Kowluru","year":"2024","unstructured":"Kowluru RA, Mohammad G, Kumar J (2024) Impaired Removal of the Damaged Mitochondria in the Metabolic Memory Phenomenon Associated with Continued Progression of Diabetic Retinopathy. Mol Neurobiol 61:188\u2013199 2023\/08\/19. https:\/\/doi.org\/10.1007\/s12035-023-03534-1","journal-title":"Mol Neurobiol"},{"key":"12925_CR14","doi-asserted-by":"crossref","first-page":"589114","DOI":"10.3389\/fphar.2020.589114","volume":"11","author":"HR Zhou","year":"2020","unstructured":"Zhou HR, Ma XF, Lin WJ et al (2020) Neuroprotective Role of GLP-1 Analog for Retinal Ganglion Cells via PINK1\/Parkin-Mediated Mitophagy in Diabetic Retinopathy. Front Pharmacol 11:589114. 2021\/03\/09","journal-title":"Front Pharmacol"},{"key":"12925_CR15","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.1038\/s41598-025-97371-y","volume":"15","author":"X Yang","year":"2025","unstructured":"Yang X, Zhang Y, Zhou Y et al (2025) CaMK2A\/CREB pathway activation is associated with enhanced mitophagy and neuronal apoptosis in diabetic retinopathy. Sci Rep 15:12516 2025\/04\/12. https:\/\/doi.org\/10.1038\/s41598-025-97371-y","journal-title":"Sci Rep"},{"key":"12925_CR16","doi-asserted-by":"crossref","first-page":"116885","DOI":"10.1016\/j.taap.2024.116885","volume":"484","author":"X Zhang","year":"2024","unstructured":"Zhang X, Su D, Wei D et al (2024) Role of MST2\/YAP1 signaling pathway in retinal cells apoptosis and diabetic retinopathy. Toxicol Appl Pharmcol 484:116885. 2024\/03\/07","journal-title":"Toxicol Appl Pharmcol"},{"key":"12925_CR17","doi-asserted-by":"publisher","first-page":"109142","DOI":"10.1016\/j.exer.2022.109142","volume":"221","author":"K Wu","year":"2022","unstructured":"Wu K, Zhou K, Zhao M et al (2022) TCF7L2 promotes ER stress signaling in diabetic retinopathy. Exp Eye Res 221:109142 2022\/06\/13. https:\/\/doi.org\/10.1016\/j.exer.2022.109142","journal-title":"Exp Eye Res"},{"issue":"11","key":"12925_CR18","doi-asserted-by":"publisher","first-page":"bqab182","DOI":"10.1210\/endocr\/bqab182","volume":"162","author":"N Warmke","year":"2021","unstructured":"Warmke N, Platt F, Bruns AF et al (2021) Pericyte insulin receptors modulate retinal vascular remodeling and endothelial angiopoietin signaling. Endocrinology 162(11):bqab182. https:\/\/doi.org\/10.1210\/endocr\/bqab182","journal-title":"Endocrinology"},{"key":"12925_CR19","doi-asserted-by":"crossref","first-page":"107830","DOI":"10.1016\/j.exer.2019.107830","volume":"189","author":"J Zeng","year":"2019","unstructured":"Zeng J, Zhao H, Chen B (2019) DJ-1\/PARK7 inhibits high glucose-induced oxidative stress to prevent retinal pericyte apoptosis via the PI3K\/AKT\/mTOR signaling pathway. Exp Eye Res 189:107830. 2019\/10\/09","journal-title":"Exp Eye Res"},{"key":"12925_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.peptides.2018.05.003","volume":"105","author":"WJ Lin","year":"2018","unstructured":"Lin WJ, Ma XF, Hao M et al (2018) Liraglutide attenuates the migration of retinal pericytes induced by advanced glycation end products. Peptides 105:7\u201313 2018\/05\/11. https:\/\/doi.org\/10.1016\/j.peptides.2018.05.003","journal-title":"Peptides"},{"key":"12925_CR21","doi-asserted-by":"crossref","first-page":"110541","DOI":"10.1016\/j.mce.2019.110541","volume":"498","author":"J Shao","year":"2019","unstructured":"Shao J, Fan G, Yin X et al (2019) A novel transthyretin\/STAT4\/miR-223-3p\/FBXW7 signaling pathway affects neovascularization in diabetic retinopathy. Mol Cell Endocrinol 498:110541. 2019\/08\/16","journal-title":"Mol Cell Endocrinol"},{"key":"12925_CR22","doi-asserted-by":"publisher","unstructured":"Forrester JV, Kuffova L, Delibegovic M (2020) The Role of Inflammation in Diabetic Retinopathy. Frontiers in immunology 11:583687. https:\/\/doi.org\/10.3389\/fimmu.2020.583687","DOI":"10.3389\/fimmu.2020.583687"},{"key":"12925_CR23","doi-asserted-by":"publisher","unstructured":"Kern TS (2007) Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Journal of Diabetes Research 2007(1):095103. https:\/\/doi.org\/10.1155\/2007\/95103","DOI":"10.1155\/2007\/95103"},{"key":"12925_CR24","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1167\/iovs.14-14671","volume":"55","author":"A Lennikov","year":"2014","unstructured":"Lennikov A, Hiraoka M, Abe A et al (2014) I\u03baB kinase-\u03b2 inhibitor IMD-0354 beneficially suppresses retinal vascular permeability in streptozotocin-induced diabetic mice. Investig Ophthalmol Vis Sci 55:6365\u20136373. 2014\/09\/11","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR25","doi-asserted-by":"publisher","unstructured":"Steinle JJ (2020) Role of HMGB1 signaling in the inflammatory process in diabetic retinopathy. Cellular signalling 73:109687. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109687","DOI":"10.1016\/j.cellsig.2020.109687"},{"key":"12925_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.exer.2012.12.009","volume":"107","author":"G Mohammad","year":"2013","unstructured":"Mohammad G, Siddiquei MM, Othman A et al (2013) High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. Exp Eye Res 107:101\u2013109. 2012\/12\/25","journal-title":"Exp Eye Res"},{"key":"12925_CR27","first-page":"164","volume":"36","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Steinle JJ (2018) HMGB1 inhibits insulin signalling through TLR4 and RAGE in human retinal endothelial cells. Growth factors (Chur. Switzerland) 36:164\u2013171. 2019\/05\/16","journal-title":"Switzerland)"},{"key":"12925_CR28","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1007\/s10753-024-02005-6","volume":"47","author":"J Tong","year":"2024","unstructured":"Tong J, Yao G, Chen Y et al (2024) Mesenchymal Stem Cells Regulate Microglial Polarization via Inhibition of the HMGB1\/TLR4 Signaling Pathway in Diabetic Retinopathy. Inflammation 47:1728\u20131743. 2024\/04\/16","journal-title":"Inflammation"},{"key":"12925_CR29","doi-asserted-by":"publisher","unstructured":"Liu H, Ghosh S, Vaidya T et al (2023) Activated cGAS\/STING signaling elicits endothelial cell senescence in early diabetic retinopathy. JCI insight 8. https:\/\/doi.org\/10.1172\/jci.insight.168945","DOI":"10.1172\/jci.insight.168945"},{"key":"12925_CR30","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41419-023-06111-5","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Zhu L, Cai MX et al (2023) TGR5 supresses cGAS\/STING pathway by inhibiting GRP75-mediated endoplasmic reticulum-mitochondrial coupling in diabetic retinopathy. Cell Death Dis 14:583 2023\/09\/02. https:\/\/doi.org\/10.1038\/s41419-023-06111-5","journal-title":"Cell Death Dis"},{"key":"12925_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.freeradbiomed.2025.03.042","volume":"233","author":"HY Li","year":"2025","unstructured":"Li HY, Wang J, Xiao T et al (2025) STING immune activation of microglia aggravating neurovascular unit damage in diabetic retinopathy. Free Radic Biol Med 233:86\u2013101 2025\/03\/31 20:02. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2025.03.042","journal-title":"Free Radic Biol Med"},{"key":"12925_CR32","doi-asserted-by":"crossref","first-page":"1151185","DOI":"10.3389\/fimmu.2023.1151185","volume":"14","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wan J, Tan G (2023) The mechanisms of NLRP3 inflammasome\/pyroptosis activation and their role in diabetic retinopathy. Front Immunol 14:1151185. 2023\/05\/14","journal-title":"Front Immunol"},{"key":"12925_CR33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41419-022-04786-w","volume":"13","author":"H Kong","year":"2022","unstructured":"Kong H, Zhao H, Chen T et al (2022) Targeted P2X7\/NLRP3 signaling pathway against inflammation, apoptosis, and pyroptosis of retinal endothelial cells in diabetic retinopathy. Cell Death Dis 13:336. 2022\/04\/13","journal-title":"Cell Death Dis"},{"key":"12925_CR34","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sinjab A, Min J et al (2025) Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell 43:905\u2013924e906. https:\/\/doi.org\/10.1016\/j.ccell.2025.03.004","journal-title":"Cancer Cell"},{"key":"12925_CR35","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/jcp.25575","volume":"232","author":"JH Yun","year":"2017","unstructured":"Yun JH, Park SW, Kim KJ et al (2017) Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy. J Cell Physiol 232:1123\u20131134. 2016\/09\/01","journal-title":"J Cell Physiol"},{"key":"12925_CR36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bbrc.2022.05.004","volume":"613","author":"JH Yun","year":"2022","unstructured":"Yun JH, Lee DH, Jeong HS et al (2022) STAT3 activation in microglia increases pericyte apoptosis in diabetic retinas through TNF-\u0251\/AKT\/p70S6 kinase signaling. Biochem Biophys Res Commun 613:133\u2013139. 2022\/05\/14","journal-title":"Biochem Biophys Res Commun"},{"key":"12925_CR37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12974-019-1533-1","volume":"16","author":"M Chen","year":"2019","unstructured":"Chen M, Obasanmi G, Armstrong D et al (2019) STAT3 activation in circulating myeloid-derived cells contributes to retinal microvascular dysfunction in diabetes. J Neuroinflamm 16:138. 2019\/07\/10","journal-title":"J Neuroinflamm"},{"key":"12925_CR38","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1167\/iovs.16-20641","volume":"58","author":"PA Vanlandingham","year":"2017","unstructured":"Vanlandingham PA, Nuno DJ, Quiambao AB et al (2017) Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy. Investig Ophthalmol Vis Sci 58:2095\u20132105. 2017\/04\/11","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR39","doi-asserted-by":"publisher","first-page":"8834","DOI":"10.1038\/s41598-017-07329-y","volume":"7","author":"PR Rothschild","year":"2017","unstructured":"Rothschild PR, Salah S, Berdugo M et al (2017) ROCK-1 mediates diabetes-induced retinal pigment epithelial and endothelial cell blebbing: Contribution to diabetic retinopathy. Sci Rep 7:8834. 2017\/08\/20","journal-title":"Sci Rep"},{"key":"12925_CR40","doi-asserted-by":"publisher","unstructured":"Wei L, Mo W, Lan S et al (2022) GLP-1 RA Improves Diabetic Retinopathy by Protecting the Blood-Retinal Barrier through GLP-1R-ROCK-p-MLC Signaling Pathway. Journal of diabetes research 2022:1861940. https:\/\/doi.org\/10.1155\/2022\/1861940","DOI":"10.1155\/2022\/1861940"},{"key":"12925_CR41","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1056\/nejm199412013312203","volume":"331","author":"LP Aiello","year":"1994","unstructured":"Aiello LP, Avery RL, Arrigg PG et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331:1480\u20131487 1994\/12\/01. https:\/\/doi.org\/10.1056\/nejm199412013312203","journal-title":"N Engl J Med"},{"key":"12925_CR42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","volume":"118","author":"AP Adamis","year":"1994","unstructured":"Adamis AP, Miller JW, Bernal MT et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445\u2013450. 1994\/10\/15","journal-title":"Am J Ophthalmol"},{"key":"12925_CR43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ajo.2004.10.004","volume":"139","author":"D Watanabe","year":"2005","unstructured":"Watanabe D, Suzuma K, Suzuma I et al (2005) Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am J Ophthalmol 139:476\u2013481. 2005\/03\/16","journal-title":"Am J Ophthalmol"},{"key":"12925_CR44","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.2337\/db13-0014","volume":"62","author":"M Rodrigues","year":"2013","unstructured":"Rodrigues M, Xin X, Jee K et al (2013) VEGF secreted by hypoxic M\u00fcller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in proliferative diabetic retinopathy. Diabetes 62:3863\u20133873. 2013\/07\/26","journal-title":"Diabetes"},{"key":"12925_CR45","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1210\/clinem\/dgab362","volume":"106","author":"J Min","year":"2021","unstructured":"Min J, Zeng T, Roux M et al (2021) The Role of HIF1\u03b1-PFKFB3 Pathway in Diabetic Retinopathy. J Clin Endocrinol Metab 106:2505\u20132519. 2021\/05\/22","journal-title":"J Clin Endocrinol Metab"},{"key":"12925_CR46","doi-asserted-by":"crossref","first-page":"156553","DOI":"10.1016\/j.metabol.2026.156553","volume":"178","author":"P Liu","year":"2026","unstructured":"Liu P, Shen N, Zhou Y et al (2026) PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis. Metab Clin Exp 178:156553. 2026\/02\/09","journal-title":"Metab Clin Exp"},{"key":"12925_CR47","doi-asserted-by":"crossref","first-page":"1615103","DOI":"10.3389\/fendo.2025.1615103","volume":"16","author":"AM Abu El-Asrar","year":"2025","unstructured":"Abu El-Asrar AM, Nawaz MI, Ahmad A et al (2025) A key role of the PGC-1\u03b1\/ERR-\u03b1 pathway in regulation of angiogenic factors in proliferative diabetic retinopathy. Front Endocrinol 16:1615103. 2025\/08\/01","journal-title":"Front Endocrinol"},{"key":"12925_CR48","doi-asserted-by":"publisher","first-page":"e10154","DOI":"10.15252\/emmm.201810154","volume":"12","author":"JH Wu","year":"2020","unstructured":"Wu JH, Li YN, Chen AQ et al (2020) Inhibition of Sema4D\/PlexinB1 signaling alleviates vascular dysfunction in diabetic retinopathy. EMBO Mol Med 12:e10154 2020\/01\/17. https:\/\/doi.org\/10.15252\/emmm.201810154","journal-title":"EMBO Mol Med"},{"key":"12925_CR49","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2353\/ajpath.2009.080945","volume":"175","author":"Y Chen","year":"2009","unstructured":"Chen Y, Hu Y, Zhou T et al (2009) Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models. Am J Pathol 175:2676\u20132685. 2009\/11\/07","journal-title":"Am J Pathol"},{"key":"12925_CR50","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/ars.2012.4583","volume":"18","author":"Q Liu","year":"2013","unstructured":"Liu Q, Li J, Cheng R et al (2013) Nitrosative stress plays an important role in Wnt pathway activation in diabetic retinopathy. Antioxid Redox Signal 18:1141\u20131153. 2012\/10\/17","journal-title":"Antioxid Redox Signal"},{"key":"12925_CR51","doi-asserted-by":"crossref","first-page":"101811","DOI":"10.1016\/j.redox.2020.101811","volume":"39","author":"J Sun","year":"2021","unstructured":"Sun J, Huang X, Niu C et al (2021) aFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt\/\u03b2-catenin-mediated upregulation of HXK2. Redox Biol 39:101811. 2020\/12\/29","journal-title":"Redox Biol"},{"key":"12925_CR52","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.2337\/db10-0148","volume":"59","author":"TL Schrufer","year":"2010","unstructured":"Schrufer TL, Antonetti DA, Sonenberg N et al (2010) Ablation of 4E-BP1\/2 prevents hyperglycemia-mediated induction of VEGF expression in the rodent retina and in Muller cells in culture. Diabetes 59:2107\u20132116. 2010\/06\/16","journal-title":"Diabetes"},{"key":"12925_CR53","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1074\/jbc.M114.623058","volume":"290","author":"MD Dennis","year":"2015","unstructured":"Dennis MD, Kimball SR, Fort PE et al (2015) Regulated in development and DNA damage 1 is necessary for hyperglycemia-induced vascular endothelial growth factor expression in the retina of diabetic rodents. J Biol Chem 290:3865\u20133874. 2014\/12\/31","journal-title":"J Biol Chem"},{"key":"12925_CR54","doi-asserted-by":"crossref","first-page":"E598","DOI":"10.1152\/ajpendo.00089.2020","volume":"320","author":"Y He","year":"2021","unstructured":"He Y, Dan Y, Gao X et al (2021) DNMT1-mediated lncRNA MEG3 methylation accelerates endothelial-mesenchymal transition in diabetic retinopathy through the PI3K\/Akt\/mTOR signaling pathway. Am J Physiol Endocrinol metabolism 320:E598\u2013e608. 2020\/12\/08","journal-title":"Am J Physiol Endocrinol metabolism"},{"key":"12925_CR55","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1167\/iovs.14-15167","volume":"55","author":"Y Cao","year":"2014","unstructured":"Cao Y, Feng B, Chen S et al (2014) Mechanisms of endothelial to mesenchymal transition in the retina in diabetes. Investig Ophthalmol Vis Sci 55:7321\u20137331. 2014\/10\/23","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR56","doi-asserted-by":"publisher","unstructured":"Luo W, Hu L, Li W et al (2016) Epo inhibits the fibrosis and migration of M\u00fcller glial cells induced by TGF-\u03b2 and high glucose. Graefe\u2019s archive for clinical and experimental ophthalmology\u2009=\u2009Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 254:881\u2013890. 2016\/02\/23 https:\/\/doi.org\/10.1007\/s00417-016-3290-5","DOI":"10.1007\/s00417-016-3290-5"},{"key":"12925_CR57","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1167\/iovs.16-19798","volume":"57","author":"K Tamaki","year":"2016","unstructured":"Tamaki K, Usui-Ouchi A, Murakami A et al (2016) Fibrocytes and Fibrovascular Membrane Formation in Proliferative Diabetic Retinopathy. Investig Ophthalmol Vis Sci 57:4999\u20135005 2016\/09\/24. https:\/\/doi.org\/10.1167\/iovs.16-19798","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR58","doi-asserted-by":"crossref","first-page":"762","DOI":"10.2337\/db21-0551","volume":"71","author":"Z Hu","year":"2022","unstructured":"Hu Z, Mao X, Chen M et al (2022) Single-Cell Transcriptomics Reveals Novel Role of Microglia in Fibrovascular Membrane of Proliferative Diabetic Retinopathy. Diabetes 71:762\u2013773. 2022\/01\/22","journal-title":"Diabetes"},{"key":"12925_CR59","doi-asserted-by":"crossref","first-page":"e2675","DOI":"10.1371\/journal.pone.0002675","volume":"3","author":"EJ Kuiper","year":"2008","unstructured":"Kuiper EJ, Van Nieuwenhoven FA, de Smet MD et al (2008) The angio-fibrotic switch of VEGF and CTGF in proliferative diabetic retinopathy. PLoS ONE 3:e2675. 2008\/07\/17","journal-title":"PLoS ONE"},{"key":"12925_CR60","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bjophthalmol-2011-301005","volume":"96","author":"RJ Van Geest","year":"2012","unstructured":"Van Geest RJ, Lesnik-Oberstein SY, Tan HS et al (2012) A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy. Br J Ophthalmol 96:587\u2013590. 2012\/02\/01","journal-title":"Br J Ophthalmol"},{"key":"12925_CR61","doi-asserted-by":"publisher","first-page":"e25166","DOI":"10.1016\/j.heliyon.2024.e25166","volume":"10","author":"G Zou","year":"2024","unstructured":"Zou G, Que L, Liu Y et al (2024) Interplay of endothelial-mesenchymal transition, inflammation, and autophagy in proliferative diabetic retinopathy pathogenesis. Heliyon 10:e25166 2024\/02\/08. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e25166","journal-title":"Heliyon"},{"key":"12925_CR62","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2016\/02\/27","volume":"164","author":"Z Zhong","year":"2016","unstructured":"Zhong Z, Umemura A, Sanchez-Lopez E et al (2016) NF-\u03baB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria. Cell 164:896. 910.2016\/02\/27","journal-title":"Cell"},{"key":"12925_CR63","doi-asserted-by":"publisher","unstructured":"Duh EJ, Sun JK, Stitt AW (2017) Diabetic retinopathy: current understanding, mechanisms, and treatment strategies. JCI insight 2. https:\/\/doi.org\/10.1172\/jci.insight.93751","DOI":"10.1172\/jci.insight.93751"},{"key":"12925_CR64","doi-asserted-by":"publisher","unstructured":"Korhonen A, Gucciardo E, Lehti K et al (2021) Proliferative diabetic retinopathy transcriptomes reveal angiogenesis, anti-angiogenic therapy escape mechanisms, fibrosis and lymphatic involvement. Scientific reports 11:18810. https:\/\/doi.org\/10.1038\/s41598-021-97970-5","DOI":"10.1038\/s41598-021-97970-5"},{"key":"12925_CR65","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1096\/fj.00-0693fje","volume":"15","author":"N Reinmuth","year":"2001","unstructured":"Reinmuth N, Liu W, Jung YD et al (2001) Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB journal: official publication Federation Am Soc Experimental Biology 15:1239\u20131241. 2001\/05\/10","journal-title":"FASEB journal: official publication Federation Am Soc Experimental Biology"},{"key":"12925_CR66","doi-asserted-by":"publisher","first-page":"5877","DOI":"10.1007\/s11010-025-05358-0","volume":"480","author":"FA Lagunas-Rangel","year":"2025","unstructured":"Lagunas-Rangel FA (2025) Sirtuins in mitophagy: key gatekeepers of mitochondrial quality. Mol Cell Biochem 480:5877\u20135896 2025\/07\/24. https:\/\/doi.org\/10.1007\/s11010-025-05358-0","journal-title":"Mol Cell Biochem"},{"key":"12925_CR67","doi-asserted-by":"publisher","unstructured":"Li Y, Liu L, Zhang Y et al (2026) Stage-Associated Cellular and Molecular Signatures in Diabetic Retinopathy Identified Through Integrated Bulk and Single-Cell Transcriptomic Analysis. International journal of molecular sciences 27. https:\/\/doi.org\/10.3390\/ijms27062775","DOI":"10.3390\/ijms27062775"},{"key":"12925_CR68","doi-asserted-by":"publisher","first-page":"118106","DOI":"10.1016\/j.biopha.2025.118106","volume":"189","author":"X Dai","year":"2025","unstructured":"Dai X, Hui X, Xi M (2025) Critical factors driving diabetic retinopathy pathogenesis and a promising interventional strategy. Biomed pharmacotherapy = Biomedecine pharmacotherapie 189:118106 2025\/06\/14. https:\/\/doi.org\/10.1016\/j.biopha.2025.118106","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"12925_CR69","doi-asserted-by":"crossref","first-page":"18316","DOI":"10.1038\/srep18316","volume":"5","author":"JR Hombrebueno","year":"2015","unstructured":"Hombrebueno JR, Ali IH, Xu H et al (2015) Sustained intraocular VEGF neutralization results in retinal neurodegeneration in the Ins2(Akita) diabetic mouse. Sci Rep 5:18316. 2015\/12\/17","journal-title":"Sci Rep"},{"key":"12925_CR70","doi-asserted-by":"crossref","first-page":"e0310949","DOI":"10.1371\/journal.pone.0310949","volume":"19","author":"E Wang","year":"2024","unstructured":"Wang E, Feng B, Chen S et al (2024) Differential microvascular endothelial cell responses in the retina in diabetes compared to the heart and kidneys, a spatial transcriptomic analysis. PLoS ONE 19:e0310949. 2025\/01\/01","journal-title":"PLoS ONE"},{"key":"12925_CR71","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1038\/s41433-025-03835-w","volume":"39","author":"S Sivaprasad","year":"2025","unstructured":"Sivaprasad S, Cheung CMG, Gliem M et al (2025) New targets in diabetic retinopathy: addressing limitations of current treatments through the Sema3A\/Nrp1 pathway. Eye 39:3209\u20133217. 2025\/07\/10","journal-title":"Eye"},{"key":"12925_CR72","doi-asserted-by":"publisher","unstructured":"Hartmane I, Mikazans I (2025) Effect of cytokine TGF-\u03b21 on pathological changes in diabetic retinopathy. Cytokine 194:157004. https:\/\/doi.org\/10.1016\/j.cyto.2025.157004","DOI":"10.1016\/j.cyto.2025.157004"},{"key":"12925_CR73","doi-asserted-by":"publisher","unstructured":"Wang X, Pan W, Zhang M et al (2025) Diabetic retinopathy from the perspective of programmed cell death: Focusing on apoptosis, pyroptosis, and necroptosis. Biochemical and biophysical research communications 788:152829. 2025\/10\/17 https:\/\/doi.org\/10.1016\/j.bbrc.2025.152829","DOI":"10.1016\/j.bbrc.2025.152829"},{"key":"12925_CR74","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/db14-0930","volume":"64","author":"JM Lachin","year":"2015","unstructured":"Lachin JM, White NH, Hainsworth DP et al (2015) Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT\/EDIC. Diabetes 64:631\u2013642. 2014\/09\/11","journal-title":"Diabetes"},{"key":"12925_CR75","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","volume":"370","author":"AC Keech","year":"2007","unstructured":"Keech AC, Mitchell P, Summanen PA et al (2007) Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet (London England) 370:1687\u20131697. 2007\/11\/09","journal-title":"Lancet (London England)"},{"key":"12925_CR76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","volume":"363","author":"EY Chew","year":"2010","unstructured":"Chew EY, Ambrosius WT, Davis MD et al (2010) Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 363:233\u2013244. 2010\/07\/01","journal-title":"N Engl J Med"},{"key":"12925_CR77","doi-asserted-by":"publisher","unstructured":"Akil H, Burgess J, Nevitt S et al (2022) Early Worsening of Retinopathy in Type 1 and Type 2 Diabetes After Rapid Improvement in Glycaemic Control: A Systematic Review. Diabetes therapy: research, treatment and education of diabetes and related disorders 13:1\u201323. 2021\/12\/20 https:\/\/doi.org\/10.1007\/s13300-021-01190-z","DOI":"10.1007\/s13300-021-01190-z"},{"key":"12925_CR78","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1167\/iovs.12-11055","volume":"54","author":"MJ Sheetz","year":"2013","unstructured":"Sheetz MJ, Aiello LP, Davis MD et al (2013) The effect of the oral PKC \u03b2 inhibitor ruboxistaurin on vision loss in two phase 3 studies. Investig Ophthalmol Vis Sci 54:1750\u20131757. 2013\/02\/14","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"12925_CR79","doi-asserted-by":"publisher","unstructured":"Boyer DS, Yoon YH, Belfort R Jr. et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121:1904\u20131914. https:\/\/doi.org\/10.1016\/j.ophtha.2014.04.024","DOI":"10.1016\/j.ophtha.2014.04.024"},{"key":"12925_CR80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamaophthalmol.2017.4914","volume":"136","author":"RK Maturi","year":"2018","unstructured":"Maturi RK, Glassman AR, Liu D et al (2018) Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial. JAMA Ophthalmol 136:29\u201338. 2017\/11\/12","journal-title":"JAMA Ophthalmol"},{"key":"12925_CR81","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/j.ophtha.2016.02.022","volume":"123","author":"JA Wells","year":"2016","unstructured":"Wells JA, Glassman AR, Ayala AR et al (2016) Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial. Ophthalmology 123:1351\u20131359. 2016\/03\/05","journal-title":"Ophthalmology"},{"key":"12925_CR82","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jamaophthalmol.2021.2809","volume":"139","author":"DM Brown","year":"2021","unstructured":"Brown DM, Wykoff CC, Boyer D et al (2021) Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial. JAMA Ophthalmol 139:946\u2013955. 2021\/08\/06","journal-title":"JAMA Ophthalmol"},{"key":"12925_CR83","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0140-6736(22)00018-6","volume":"399","author":"CC Wykoff","year":"2022","unstructured":"Wykoff CC, Abreu F, Adamis AP et al (2022) Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials. Lancet (London England) 399:741\u2013755. 2022\/01\/28","journal-title":"Lancet (London England)"},{"key":"12925_CR84","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamaophthalmol.2025.0006","volume":"143","author":"AM Khanani","year":"2025","unstructured":"Khanani AM, Campochiaro PA, Graff JM et al (2025) Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. JAMA Ophthalmol 143:326\u2013335. 2025\/03\/06","journal-title":"JAMA Ophthalmol"},{"key":"12925_CR85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jamaophthalmol.2025.0001","volume":"143","author":"DJ Pieramici","year":"2025","unstructured":"Pieramici DJ, Awh CC, Chang M et al (2025) Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial. JAMA Ophthalmol 143:317\u2013325. 2025\/03\/06","journal-title":"JAMA Ophthalmol"},{"key":"12925_CR86","doi-asserted-by":"publisher","unstructured":"Sejournet L, Mathis T, Vermot-Desroches V et al (2024) Efficacy and Safety of Fluocinolone Acetonide Implant in Diabetic Macular Edema: Practical Guidelines from Reference Center. Pharmaceutics 16. https:\/\/doi.org\/10.3390\/pharmaceutics16091183","DOI":"10.3390\/pharmaceutics16091183"},{"key":"12925_CR87","doi-asserted-by":"publisher","unstructured":"Odio-Herrera M, Orozco-Loaiza G, Wu L (2025) Gene Therapy in Diabetic Retinopathy and Diabetic Macular Edema: An Update. Journal of clinical medicine 14. https:\/\/doi.org\/10.3390\/jcm14093205","DOI":"10.3390\/jcm14093205"},{"key":"12925_CR88","doi-asserted-by":"crossref","first-page":"118911","DOI":"10.1016\/j.biopha.2025.118911","volume":"194","author":"M Johari","year":"2026","unstructured":"Johari M, Baghban R, Salari R et al (2026) Revolutionizing uveitis treatment with nanotechnology: Innovations, barriers, and strategic solutions. Biomed pharmacotherapy = Biomedecine pharmacotherapie 194:118911. 2026\/01\/07","journal-title":"Biomed pharmacotherapy = Biomedecine pharmacotherapie"},{"key":"12925_CR89","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.ophtha.2023.12.026","volume":"131","author":"TY Wong","year":"2024","unstructured":"Wong TY, Haskova Z, Asik K et al (2024) Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials. Ophthalmology 131:708\u2013723. 2024\/01\/02","journal-title":"Ophthalmology"},{"key":"12925_CR90","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ophtha.2026.01.001","volume":"133","author":"VS Sheth","year":"2026","unstructured":"Sheth VS, Schlottmann P, Lai TYY et al (2026) Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results from the RHONE-X Extension Trial. Ophthalmology 133:599 2026\/01\/15. https:\/\/doi.org\/10.1016\/j.ophtha.2026.01.001","journal-title":"Ophthalmology"},{"key":"12925_CR91","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000500026","volume":"62","author":"TS Kern","year":"2019","unstructured":"Kern TS, Antonetti DA, Smith LEH (2019) Pathophysiology of Diabetic Retinopathy: Contribution and Limitations of Laboratory Research. Ophthalmic Res 62:196\u2013202 2019\/07\/31. https:\/\/doi.org\/10.1159\/000500026","journal-title":"Ophthalmic Res"},{"key":"12925_CR92","doi-asserted-by":"publisher","unstructured":"Corano Scheri K, Lavine JA, Tedeschi T et al (2023) Single-cell transcriptomics analysis of proliferative diabetic retinopathy fibrovascular membranes reveals AEBP1 as fibrogenesis modulator. JCI insight 8. https:\/\/doi.org\/10.1172\/jci.insight.172062","DOI":"10.1172\/jci.insight.172062"},{"key":"12925_CR93","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/S0140-6736(24)00310-6","volume":"403","author":"PA Campochiaro","year":"2024","unstructured":"Campochiaro PA, Avery R, Brown DM et al (2024) Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1\/2a dose-escalation study. Lancet (London England) 403:1563\u20131573. 2024\/03\/31","journal-title":"Lancet (London England)"},{"key":"12925_CR94","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD et al (2020) Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 383:2219\u20132229. 2020\/12\/03","journal-title":"N Engl J Med"},{"key":"12925_CR95","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bjophthalmol-2021-319587","volume":"107","author":"SK Szeto","year":"2023","unstructured":"Szeto SK, Hui VWK, Tang FY et al (2023) OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study. Br J Ophthalmol 107:525\u2013533. 2021\/11\/10","journal-title":"Br J Ophthalmol"},{"key":"12925_CR96","doi-asserted-by":"publisher","unstructured":"Udaondo P, Hern\u00e1ndez C, Brians\u00f3-Llort L et al (2019) Usefulness of Liquid Biopsy Biomarkers from Aqueous Humor in Predicting Anti-VEGF Response in Diabetic Macular Edema: Results of a Pilot Study. Journal of clinical medicine 8. https:\/\/doi.org\/10.3390\/jcm8111841","DOI":"10.3390\/jcm8111841"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12925-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12925-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12925-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:22:33Z","timestamp":1792160553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12925-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12925"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12925-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"3 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"not applicable.","order":2,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1741"}}